Moderna斥资9.5亿美元与Arbutus及Roivant达成新冠疫苗专利索赔和解。
Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
生命科学资讯
生物技术与制药领域的最新动态
欧洲药品管理局推荐Moderna流感-新冠联合疫苗及诺华荨麻疹药片。
CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives
Moderna联合流感与新冠疫苗获欧洲药品监管机构认可。
Moderna’s combination flu, COVID shot wins over European drug regulators
潜在Eylea竞争对手令人失望；FDA将审查Moderna流感疫苗；又一罕见病疗法遭拒；及其他动态。
Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
白宫不满或促使FDA收回对Moderna的批准：Politico报道
White House frustration may have fueled FDA’s Moderna walkback: Politico
FDA在迅速重新考虑后接受Moderna流感疫苗申请。
FDA accepts filing for Moderna flu vaccine after swift rethink
Moderna流感疫苗申请在FDA经历非典型路径后出现逆转。
Reversal on Moderna's flu application follows atypical path through FDA
FDA撤销对Moderna流感疫苗的批准决定。
FDA reverses course on Moderna’s flu vaccine
FDA转变立场，将审查莫德纳流感疫苗。
FDA reverses course, will review Moderna’s flu vaccine
Moderna在Arbutus的mRNA专利战中遭遇挫折。
Moderna faces setback in Arbutus' mRNA patent fight
Moderna与FDA之争；赛诺菲CEO保罗·哈德森离职；临床试验为何如此昂贵；及其他动态
Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
随着FDA对Moderna的决定，疫苗制造商面临日益不确定的监管环境
With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
Moderna 2025年研发支出锐减31%，源于重大管线重组。
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Moderna流感疫苗困境令2028年盈亏平衡指引蒙上阴影。
Moderna's flu shot dilemma muddies 2028 break-even guidance
Moderna股价飙升，公司确认增长前景乐观。
Moderna shares jump as company affirms growth outlook
更新：在莫德纳遭拒后，美国卫生与公众服务部支持FDA驳回mRNA流感疫苗申请的决定。
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
FDA或考虑在更小范围使用Moderna流感疫苗
FDA may consider Moderna's flu vaccine in a narrower group
普拉萨德否决疫苗审查团队及办公室主管对Moderna流感疫苗的建议。
Prasad overruled vaccine review team, office director on Moderna flu shot
Moderna因流感疫苗RTF信函股价下跌
Moderna dips on flu vaccine RTF letter
FDA拒绝审查Moderna的mRNA流感疫苗。
FDA refuses to review Moderna’s mRNA flu vaccine